A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS) | MicrobiomeTrials
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2021-12-14Est. Completion: 2027-09-30
Enrollment target: 188 participants
Locations
Barnet Dulaney Perkins Eye Center, Mesa, Arizona, United States
California Retina Consultants, Bakersfield, California, United States
Retina Associates of Southern California, Huntington Beach, California, United States
California Eye Specialists Medical group Inc., Pasadena, California, United States
Retinal Consultants Med Group, Sacramento, California, United States
University of California San Francisco, San Francisco, California, United States
Orange County Retina Med Group, Santa Ana, California, United States
Macula Retina Vitreous Research Institute, Torrance, California, United States
Southwest Retina Consultants, Durango, Colorado, United States
Advanced Vision Research Institute, Longmont, Colorado, United States
Retina Group of New England, Waterford, Connecticut, United States
Retina Specialty Institute, Pensacola, Florida, United States
Ft Lauderdale Eye Institute, Plantation, Florida, United States
Retina Vitreous Associates of Florida, St. Petersburg, Florida, United States
Southeast Retina Center, Augusta, Georgia, United States
Other microbiome trials you might be interested in